K23HL143156

NIH – National Heart, Lung, and Blood Institute

Visit this grant

Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)

Jackson, L. R., Schrader, P., Thomas, L., Steinberg, B. A., Blanco, R., Allen, L. A., Fonarow, G. C., Freeman, J. V., Gersh, B. J., Kowey, P. R., Mahaffey, K. W., Naccarelli, G., Reiffel, J., Singer, D. E., Peterson, E. D., & Piccini, J. P. (2021). Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II). American Journal of Cardiovascular Drugs, 21(5), 553–561. https://doi.org/10.1007/s40256-021-00473-x
Authors:
Larry R. Jackson
Peter Schrader
Laine Thomas
Benjamin A. Steinberg
Rosalia Blanco
Larry A. Allen
Gregg C. Fonarow
James V. Freeman
Bernard J. Gersh
Peter R. Kowey
Kenneth W. Mahaffey
Gerald Naccarelli
James Reiffel
Daniel E. Singer
Eric D. Peterson
Jonathan P. Piccini
Affiliated Authors:
James Reiffel
Columbia Affiliation:
Subjects:
Anticoagulants (MeSH)
Renal Insufficiency, Chronic (MeSH)
Grants:
K23HL143156 (NIH – National Heart, Lung, and Blood Institute)
Publication Type:
Article
Unique ID:
10.1007/s40256-021-00473-x
PMID:
33786798
DOI:
10.1007/s40256-021-00473-x
Journal:
American Journal of Cardiovascular Drugs
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created:

CSV